Travel | Accommodations
History of the symposium
September 15-17, 2016
September 14-16, 2017
- Brian C. Leonard, MD, Symposium Organizer
- William F. Mieler, MD, Chair
- Michael Dollin, MD, Co-chair | Retina
- Kashif Baig, MBA, MD | Cornea/Refractive
- David Chang, MD | Cataract
- Jay S. Duker, MD | Retina (imaging)
- J. William Harbour, MD | Ocular tumours
- Mark Humayun, MD | Retina (research)
- Jennifer J. Kang-Mieler, PhD | Retina (research)
- Andrew Lee, MD | Neuro-ophthalmology
- Garfield Miller, MD | Glaucoma
- David Sarraf, MD | Retina (hereditary/imaging)
- R. Michael Siatkowski, MD | Pediatric ophthalmology
- Kuldev Singh, MD | Glaucoma
- Steven Yeh, MD | Uveitis
- Michael Tze-Chien Yen, MD | Oculoplastics/Orbit
- Sonia Yoo, MD
Brian Leonard, MD
Professor of Ophthalmology
University of Ottawa Eye Institute
The Sally Letson Foundation
Dr. Leonard is a vitreoretinal surgeon at the University of Ottawa Eye Institute. He was the Eye Institute's founding director and led its planning and development team, from conception to construction. He is also professor of ophthalmology and past-chair of the Department of Ophthalmology, University of Ottawa Medical School.
Dr. Baig is a cornea, anterior segment, and refractive surgeon providing tertiary and quaternary level care at the University of Ottawa Eye Institute. He is an assistant professor at the University of Ottawa, cornea consultant at the Children's Hospital of Eastern Ontario, principal investigator at the Ottawa Hospital Research Institute, and director of clinical and research fellowships in cornea, anterior segment, and refractive surgery. He is also the president of the Canadian Cornea, External Disease, and Refractive Surgery Society. He completed his medical and residency training at McGill University, Master of Business Administration degree (Health Services Management) at McMaster University, and fellowship training in the United States. He has a strong interest in the development and implementation of surgical innovations in corneal and anterior segment surgery.
David F. Chang, MD is a summa cum laude graduate of Harvard College and Harvard Medical School. He completed his ophthalmology residency at the University of California, San Francisco. where he is now a clinical professor. Dr. Chang has been on the ASCRS Board and Executive Committee since 2009 and served as the 2012-2013 president. He is immediate past chair of the AAO Cataract PPP Panel and in 2009 completed his 5-year term as chair of the AAO Annual Meeting Program Committee. Dr. Chang also co-chairs the ASCRS Foundation. He has served as chief medical editor of EyeWorld and co-chief medical editor for Cataract and Refractive Surgery Today.
In 2006, Dr. Chang became only the third ophthalmologist to ever receive the Charlotte Baer Award honoring the outstanding clinical faculty member at the UCSF Medical School. He has received the highest honor for cataract surgery or for an international ophthalmologist from the following organizations: ASCRS (Binkhorst Medal), AAO (Kelman Lecture), Asia Pacific Association of Cataract & Refractive Surgery (Lim Medal), United Kingdom and Ireland Society of Cataract & Refractive Surgery (Rayner Medal), Canadian Society of Cataract and Refractive Surgery (Award of Excellence/Stein Lecture), All India Ophthalmology Society (President's Lecture), Indian Intraocular Implant & Refractive Society (Gold Medal), Italian Ophthalmological Society (Strampelli Medal), Royal Australia and New Zealand College of Ophthalmologists (Gregg Medal), and the Asia-Pacific Academy of Ophthalmology (Jose Rizal International Medal). In 2014, he was also voted the 5th most influential ophthalmologist in the world by the international readership of The Ophthalmologist.
Dr. Dollin is currently a vitreoretinal surgeon and assistant professor at the University of Ottawa Eye Institute. He received his honours bachelor of science degree with high distinction and doctor of medicine degree from the University of Toronto. He completed his internship and residency training in ophthalmology at the University of Ottawa, where he was appointed co-chief resident. During his residency, he was awarded the Department of Ophthalmology Resident Teaching Award, and was twice presented with The Ottawa Hospital Guardian Angel Pin Award. He went on to complete a Retina fellowship at the prestigious Wills Eye Hospital in Philadelphia, where he was awarded the P. Robb McDonald Award for best fellow research paper at the Wills Eye Hospital Annual Alumni Conference two years in a row.
Dr. Dollin is a member of the Royal College of Physicians and Surgeons of Canada, the Canadian Ophthalmological Society, the American Academy of Ophthalmology, the American Society of Retina Specialists, the Association for Research in Vision and Ophthalmology, and the Ontario and Canadian Medical Associations.
Dr. Dollin currently serves as the Eye Institute's principal investigator on several major multicentre clinical trials and has presented his own research at large national and international academic meetings. He has co-authored scientific papers, book chapters, and non-peer reviewed articles. He serves as a reviewer for the journal Retina and the Canadian Journal of Ophthalmology. His primary research interests include Age-related Macular Degeneration and Diabetic Macular Edema. He enjoys being actively involved in research at the University of Ottawa, as well as the teaching of medical students, residents, and Retina fellows.
Jay S. Duker
Jay S. Duker, MD, is professor and chairman, Department of Ophthalmology at Tufts Medical Center and Tufts University School of Medicine and the director of the New England Eye Center in Boston, Massachusetts. The New England Eye Center is one of the largest and busiest academic practices in the country. Dr. Duker received his medical degree magna cum laude from Jefferson Medical College in Philadelphia, PA. He completed an internal medicine internship at the Beth Israel Hospital in Boston, MA. Dr. Duker then completed an ophthalmology residency, serving as chief resident, followed by a retina and vitreous surgery fellowship, at the Wills Eye Hospital in Philadelphia.
Dr. Duker's major research interests include imaging of the posterior segment, retinal vascular disease, and drug delivery to the posterior segment. He has pursued those interests as a co-Investigator or principal investigator of numerous studies funded by the National Institutes of Health/National Eye Institute, Massachusetts Institute of Technology, and industry, including studies of optical coherence tomography and several phase III trials. Specializing in medical and surgical diseases of the posterior segment, his surgical expertise includes macular diseases, retinal detachment, proliferative vitreoretinopathy, diabetic retinopathy and intraocular tumors. He has been over 185 journal articles published, and he has authored 5 text books and dozens of book chapters. In addition, Dr. Duker lectures extensively both nationally and internationally. He is the editor of the International Journal of Retina and Vitreous, the associate editor of OSLI Retina, and has served on the editorial boards of Investigative Ophthalmology and Visual Science, Review of Ophthalmology, Evidence-Based Eye Care, and Retina Today. He has been a reviewer for many journals including Ophthalmology, American Journal of Ophthalmology, Archives of Ophthalmology, Ophthalmic Surgery and Lasers, Retina, and the New England Journal of Medicine, among others. Dr. Duker is the recipient of an honour award and senior honour award from the American Academy of Ophthalmology and the American Society of Retina Specialists. In addition, he is the founder of three companies including Hemera Biosciences, a biotech start-up whose focus is a gene therapy based treatment for age-related macular degeneration.
J. William Harbour
Dr. Harbour received his medical degree from Johns Hopkins University in 1990, followed by a residency in ophthalmology at the Wills Eye Hospital in Philadelphia, and clinical fellowships in vitreoretinal diseases at the Bascom Palmer Eye Institute in Miami, and ocular oncology at the University of California in San Francisco. He obtained research fellowship training at the National Cancer Institute and in the Division of Molecular Oncology at Washington University. He was on the faculty of Washington University in St. Louis for 16 years and reached the position of distinguished professor of ophthalmology and visual sciences. He is currently the vice chair for translational research and director of the Ocular Oncology Service at the Bascom Palmer Eye Institute of the University of Miami, where he has a joint appointment in the Sylvester Cancer Center and oversees a multi-disciplinary team of physicians and scientists studying the genetics and genomics of major eye cancers.
Mark S. Humayun
Dr. Humayun, MD, PhD, is the Cornelius J. Pings Chair in Biomedical Sciences, professor of ophthalmology, biomedical engineering, and cell and neurobiology, director of the Institute for Biomedical Therapeutics, director of Sensory Sciences Institute, and co-eirector of the USC Eye Institute at the University of Southern California.
Dr. Humayun's research focuses at the intersection of Engineering and Medicine on the development of biomimetic bioelectronics for medical applications with a special focus on ophthalmological and neurological diseases. He is a member of the National Academy of Engineering and the National Academy of Medicine (formerly Institute of Medicine). He is an IEEE Fellow. He was named inventor of the year in 2005 by R&D Magazine. He is also recognized as one of the Best Doctors in the country and in 2011 US News and World report listed him in the top 1% of Ophthalmologists.
Dr. Humayun is the founding director of the NSF ERC Biomimetic Microelectronic Systems Engineering Research Center. He has more than 150 peer-reviewed publications, authored more than 20 book chapters and is listed as an inventor on more than 100 patents/patents applications. His work has led to the formation of multiple start-up companies. He is recognized internationally as the inventor of an artificial bioelectronic retina to restore sight to the blind. The artificial retina called Argus II was recently approved by FDA as the first bioelectronics retinal implant to restore sight to certain blind patients.
Jennifer J. Kang-Mieler
Dr. Kang-Mieler is an associate professor of biomedical engineering at the Illinois Institute of Technology, Chicago, IL, USA. She received her BA in mathematics, MS in applied mathematics and PhD in biomedical engineering from the Northwestern University. She completed post-doctoral fellowship at the University of Illinois at Chicago in the Department of Ophthalmology and Visual Sciences. Dr. Kang-Mieler's research interests include translational research such as ocular drug delivery, nitric oxide sensor development, retinal blood flow and modeling to name few. Dr. Kang-Mieler is an active member of the Macula Society, the Retina Society, the American Society of Retina Specialists, Association for Research in Vision and Ophthalmology, the Biomedical Engineering Society and the Dowling society to name few. She recently became a trustee member presenting retina section at ARVO.
Andrew G. Lee
Dr. Lee is chair of the Jack S. Blanton Sr. Eye Institute of the Houston Methodist Hospital in the Texas Medical Center. He is professor of ophthalmology, neurology, and neurosurgery at Weill Cornell Medical College; adjunct professor of ophthalmology at the University of Iowa and at Baylor College of Medicine; clinical professor at the University of Texas Medical Branch in Galveston, Texas, the UT MD Anderson Cancer Center, and the University of Buffalo, SUNY.
Dr. Lee has served on the national and international Editorial Board of 15 journals including JAMA Ophthalmology, the American Journal of Ophthalmology, the Canadian Journal of Ophthalmology, the Japanese Journal of Ophthalmology, the Journal of Neuro-ophthalmology, Survey of Ophthalmology, and Eye and is the editor in chief of the Journal of Clinical and Academic Ophthalmology.
He has published over 400 peer-reviewed publications, 40 book chapters, and nine full textbooks in ophthalmology. He has been the invited speaker at over 400 national and international eye meetings and has given 12 named lectureships. Dr. Lee has a special interest in graduate medical education and has received the resident teaching award six times at five different academic institutions.
William F. Mieler
Dr. Mieler is the Cless Family Professor of Ophthalmology, and vice-chair for education, in the Department of Ophthalmology & Visual Sciences at the University of Illinois at Chicago, Chicago, IL. He also serves as the residency program director, and as the director of vitreoretinal fellowship training. His specialty areas include diseases and surgery of the retina and vitreous, along with ocular oncology.
Dr. Mieler received his doctorate of medicine at the University of Wisconsin-Madison, Medical School (1979). After completion of his internship at Mercy Hospital Medical Center in San Diego, CA (1980), he completed his three-year ophthalmology residency at the Bascom Palmer Eye Institute, University of Miami, Miami, FL (1980-83). This was followed by a one-year vitreoretinal fellowship at the Eye Institute, Medical College of Wisconsin, Milwaukee, WI (1983-84). He then returned to the Bascom Palmer Eye Institute where he served as Chief Resident and Clinical Instructor (1984-85). Dr. Mieler then completed a second fellowship in ocular oncology, at Wills Eye Hospital, Thomas Jefferson University, Philadelphia, PA (1985). In 1985, he joined the full-time faculty at the Medical College of Wisconsin, where he became professor of ophthalmology (1992) and was awarded the Jack A. and Elaine D. Klieger Chair in Ophthalmology (1998). Dr. Mieler then joined the faculty at the Baylor College of Medicine, in Houston, TX, as professor of ophthalmology (1999-2004). He then accepted the position of professor and chair, Department of Ophthalmology, at the University of Chicago (2004-08), prior to his current position at the University of Illinois at Chicago (2008-present).
Dr. Mieler has authored or co-authored 335 scientific papers, 70 book chapters, and 5 textbooks. He is/has been the principle investigator or co-investigator of more than 60 scientific grants and collaborative studies. He has served the American Board of Ophthalmology (ABO) as a board director (1997-2005), chair of the board (2005), as associate executive director (2006), and as emeritus director (2006-present). He serves on several committees with the American Board of Medical Specialties (ABMS). Dr. Mieler is also the past President of the Macula Society (2003-04), and he recently received the Gass Medal (2013). He has served on the Executive Committees of the Retina Society and the American Society of Retina Specialists (ASRS). In 2011, he was named recipient of the Founders Award by the ASRS. He is a past member of the Pan-American Board of Directors (2001-08), and he currently chairs the Foundation Grants Committee (2006-present). Dr. Mieler currently serves on the ARVO Board of Trustees (2010-15), representing the retina section, and is president of ARVO (2014-15). He has served on the Editorial Board of Archives of Ophthalmology, Retina, and Current Eye Research, and he also serves as a scientific reviewer for 31 additional scientific journals. From the American Academy of Ophthalmology (AAO), he has received the Honor Award (1992), the Lifelong Education for the Ophthalmologist Award (2000), the Senior Honor Award (2001), and the Life Achievement Honor Award (2011). He also has served as a member of the AAO Council (2001-08), the EyeNet Editorial Advisory Board (2003-07), and the chair of the Schepens Award (2007-10). He continues to serve the AAO as a media spokesperson (2001-present), as a member of the CME Committee, and as associate secretary for the AAO subspecialty day programs (2011-15).
Garfield Miller is an ophthalmologist and assistant professor at the University of Ottawa Eye Institute. He completed a fellowship under the tutelage of Dr. Ike Ahmed in glaucoma and advanced anterior segment surgery. Dr. Miller specializes in surgical glaucoma, complicated cataracts, and anterior segment repair. He has an interest in teaching as well as clinical research. Peer reviewed publications have included papers in the Journal of Cataract and Refractive Surgery, the Journal of Glaucoma, and the Canadian Journal of Ophthalmology. Invited lectures and presentations have been given at the American Society of Cataract and Refractive Surgery meeting, Canadian Ophthalmological Society meeting and others. In addition, Dr. Miller has a global interest in medicine having done short-term missions in Swaziland and Niger.
Dr. David Sarraf is clinical professor of ophthalmology at the Stein Eye Institute at UCLA and member of the Retinal Disorders and Ophthalmic Genetics Division. He has published over 100 research papers, case reports, reviews and book chapters.
Dr. Sarraf's focus of research interest is the dry and wet forms of age-related macular degeneration (AMD) and specifically the evaluation of pigment epithelial detachment and retinal pigment epithelial tears.
He is a leader in advanced retinal imaging and has published extensively in the area spectral domain OCT analysis of AMD and other novel and established macular disorders. He was one of the first researchers to describe ischemia of the deep retinal capillary plexus using advanced SD OCT imaging and is a world expert on the clinical application of OCT angiography.
Dr. Sarraf is associate editor for the journals Retinal Cases and Brief Reports and OSLI Retina. He is a member of the BCSC section of the AAO that has completed the most recent edition of the retina volume and has been awarded achievement and secretariat awards by the AAO.
Dr. Sarraf is also co-director of the Pacific Retina Club and the International Retinal Imaging Symposium and is a member of the ASRS, Retina Society and Gass Club and is an executive board member in the Macula Society. Dr. Sarraf was recently nominated to the American Ophthalmological Society because of his research work in age related macular degeneration.
R. Michael Siatkowski
Dr. Siatkowski is the David W. Parke II, MD professor of ophthalmology and vice chair for academic affairs at the University of Oklahoma/Dean McGee Eye Institute, where he also serves as residency program director. His clinical focus is in pediatric ophthalmology and strabismus, as well as neuro-ophthalmology, with particular interest in eye movement disorders, pediatric neuro-ophthalmology, and retinopathy of prematurity.
Dr. Siatkowski has authored over 100 peer-reviewed publications and is a director of the American Board of Ophthalmology. He is active in various roles in the American Academy of Ophthalmology, and the American Association for Pediatric Ophthalmology and Strabismus. Dr. Siatkowski has been a member of the Residency Review Committee for Ophthalmology since 2008 and currently serves as vice chair. He was inducted into the American Ophthalmological Society in 2011. Dr. Siatkowski is married to Rhea L. Siatkowski, MD, a cornea and anterior segment surgeon, and they have three children, Abigail, Elizabeth, and Joshua.
Kuldev Singh is professor of ophthalmology and director of the Glaucoma Service at Stanford University. He received his MD and MPH degrees from the Johns Hopkins University and residency training at the Casey Eye Institute. He completed a research fellowship at the Wilmer Eye Institute and a clinical fellowship at the Bascom Palmer Eye Institute. Dr. Singh has served as president of the American Glaucoma Society, executive vice president of the World Glaucoma Association and board chair for the Glaucoma Research Foundation. He is a member of the FDA Advisory Committee on Ophthalmic Devices and a consultant for the National Space Biomedical Research Institute. Dr. Singh's current research interests include glaucoma and cataract surgical trials, epidemiology, genetics as well as health care delivery in underserved communities in the United States and overseas. His clinical practice focuses on the medical, laser and surgical management of glaucoma and cataract.
Dr. Yeh is the director of the Uveitis Service at Emory University. He is an associate professor in ophthalmology and specializes in the care of patients with uveitis and vitreoretinal surgical diseases. After residency training at the Cullen Eye Institute, Baylor College of Medicine, he completed a combined uveitis and medical retina fellowship at the National Eye Institute, National Institutes of Health, followed by a vitreoretinal surgery fellowship at the Casey Eye Institute, Oregon Health and Science University.
Dr. Yeh's clinical and research interests include diagnostic imaging for the management of posterior uveitis, local and systemic immunotherapy for adult and pediatric noninfectious uveitis, and more recently, the management of Ebola-associated uveitis and herpetic viral retinitis. He currently serves on the Ophthalmic Technology Assessment Committee and the Uveitis Knowledge Base Panel of the American Academy of Ophthalmology. Dr. Yeh has also received the Honor Award from the American Society of Retina Specialists.
Michael T. Yen
Michael T. Yen, MD, specializes in cosmetic and reconstructive surgery of the eyelids and face. He attended medical school at the University of Michigan and completed his residency at the Bascom Palmer Eye Institute in Miami. A fellowship in ophthalmic and facial plastic surgery with Dr. Richard Anderson in Salt Lake City followed.
Dr. Yen is currently a professor of ophthalmology at the Cullen Eye Institute, Department of Ophthalmology, Baylor College of Medicine. He is also medical director of the Alkek Eye Center and co-director of Baylor College of Medicine Aesthetics. He has been principal investigator in various research trials, authored over 85 peer-reviewed journal publications, and edited two previous books on surgery of the eyelids and advances in aesthetic and reconstructive oculofacial plastic surgery.
Dr. Yen is the recipient of a number of awards, including, in 2013, the Senior Achievement Award from the American Academy of Ophthalmology.
Sonia H. Yoo, MD, is currently professor of ophthalmology with a joint appointment in biomedical engineering and associate medical director at Bascom Palmer Eye Institute, University of Miami Miller School of Medicine. Dr. Yoo received her BA at Stanford University in California and her MD at Case Western Reserve University in Ohio. She completed residency and fellowship at Massachusetts Eye and Ear Infirmary of Harvard Medical School in 1998.
Dr. Yoo's areas of clinical practice are cornea, cataract, and refractive surgery. Her areas of research interest are in laser applications in cornea, cataract and refractive surgery, and restoring accommodation. She holds several patents and has authored more than 150 book chapters and peer-reviewed journal articles as well as serving as the principal investigator in numerous drug and device trials.
Dr. Yoo has a history of service to her field. This year, Dr. Yoo served as the program chair of the Refractive Surgery subspecialty day program of the American Academy of Ophthalmology (AAO) and received the International Society of Refractive Surgery's prestigious Founder's Award for her accomplishments in cataract and refractive surgery. She serves on the AAO's Practicing Ophthalmologists Curriculum Refractive Management/Intervention Panel for refractive surgery, is a board member of the American Society of Cataract and Refractive Surgery, and is on the board of directors for the Cornea Society. She is a reviewer for numerous ophthalmology journals and serves on the editorial board of the Cornea Society, the Journal of Refractive Surgery, and the Journal of Cataract and Refractive Surgery. Dr. Yoo served as the cornea fellowship director at Bascom Palmer Eye Institute from 2000-2013 and has trained numerous residents, clinical fellows, and international research fellows during her career.
Performing eye surgery for the past 20 years, Dr. Yoo continually strives to improve patient outcomes. She is currently working on the use of optical coherence tomography imaging to aid visualization during surgery. She is also using this technology to develop a novel imaging device for the early detection of keratoconus.